Morris, K. V. & Mattick, J. S. The rise of regulatory RNA. Nat. Rev. Genet. 15, 423–437 (2014).
Google Scholar
Deogharia, M. & Gurha, P. The ‘guiding’ principles of noncoding RNA function. Wiley Interdiscip. Rev. RNA 13, e1704 (2022).
Google Scholar
Winkle, M., El-Daly, S. M., Fabbri, M. & Calin, G. A. Noncoding RNA therapeutics — challenges and potential solutions. Nat. Rev. Drug Discov. 20, 629–651 (2021).
Google Scholar
Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022).
Google Scholar
Singh, G., Pratt, G., Yeo, G. W. & Moore, M. J. The clothes make the mRNA: past and present trends in mRNP fashion. Annu. Rev. Biochem. 84, 325–354 (2015).
Google Scholar
Hentze, M. W., Castelló, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 3, 195 (2018).
Roden, C. & Gladfelter, A. S. RNA contributions to the form and function of biomolecular condensates. Nat. Rev. Mol. Cell Biol. 22, 183–195 (2021).
Google Scholar
Wiedner, H. J. & Giudice, J. It’s not just a phase: function and characteristics of RNA-binding proteins in phase separation. Nat. Struct. Mol. Biol. 28, 465–473 (2021).
Google Scholar
Corley, M., Burns, M. C. & Yeo, G. W. How RNA-binding proteins interact with RNA: molecules and mechanisms. Mol. Cell 78, 9–29 (2020).
Google Scholar
Imig, J., Kanitz, A. & Gerber, A. P. RNA regulons and the RNA-protein interaction network. Biomol. Concepts 3, 403–414 (2012).
Google Scholar
Gebauer, F., Schwarzl, T., Valcárcel, J. & Hentze, M. W. RNA-binding proteins in human genetic disease. Nat. Rev. Genet. 22, 185–198 (2021).
Google Scholar
Prashad, S. & Gopal, P. P. RNA-binding proteins in neurological development and disease. RNA Biol. 18, 972–987 (2021).
Google Scholar
Giudice, J. & Cooper, T. A. RNA-binding proteins in heart development. Adv. Exp. Med. Biol. 825, 389–429 (2014).
Google Scholar
Harvey, R. P. Patterning the vertebrate heart. Nat. Rev. Genet. 3, 544–556 (2002).
Google Scholar
Boada, C., Sukhovershin, R., Pettigrew, R. & Cooke, J. P. RNA therapeutics for cardiovascular disease. Curr. Opin. Cardiol. 36, 256–263 (2021).
Google Scholar
Lu, D. & Thum, T. RNA-based diagnostic and therapeutic strategies for cardiovascular disease. Nat. Rev. Cardiol. 16, 661–674 (2019).
Google Scholar
Santovito, D. & Weber, C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat. Rev. Cardiol. 19, 620–638 (2022).
Google Scholar
Peters, L. J. F. et al. Small things matter: relevance of MicroRNAs in cardiovascular disease. Front. Physiol. 11, 793 (2020).
Google Scholar
Gao, C. & Wang, Y. mRNA metabolism in cardiac development and disease: life after transcription. Physiol. Rev. 100, 673–694 (2020).
Google Scholar
Gatsiou, A. & Stellos, K. RNA modifications in cardiovascular health and disease. Nat. Rev. Cardiol. 20, 325–346 (2022).
Google Scholar
Gotthardt, M. et al. Cardiac splicing as a diagnostic and therapeutic target. Nat. Rev. Cardiol. 20, 517–530 (2023).
Google Scholar
Ramanathan, M., Porter, D. F. & Khavari, P. A. Methods to study RNA–protein interactions. Nat. Methods 16, 225–234 (2019).
Google Scholar
Gerber, A. P. RNA-centric approaches to profile the RNA–protein interaction landscape on selected RNAs. Noncoding RNA 7, 11 (2021).
Google Scholar
Smith, J. M., Sandow, J. J. & Webb, A. I. The search for RNA-binding proteins: a technical and interdisciplinary challenge. Biochem. Soc. Trans. 49, 393–403 (2021).
Google Scholar
McHugh, C. A., Russell, P. & Guttman, M. Methods for comprehensive experimental identification of RNA-protein interactions. Genome Biol. 15, 203 (2014).
Google Scholar
Faoro, C. & Ataide, S. F. Ribonomic approaches to study the RNA‐binding proteome. FEBS Lett. 588, 3649–3664 (2014).
Google Scholar
Hockensmith, J. W., Kubasek, W. L., Vorachek, W. R. & von Hippel, P. H.Laser cross-linking of proteins to nucleic acids. I. Examining physical parameters of protein-nucleic acid complexes. J. Biol. Chem. 268, 15712–15720 (1993).
Google Scholar
Pashev, I. G., Dimitrov, S. I. & Angelov, D. Crosslinking proteins to nucleic acids by ultraviolet laser irradiation. Trends Biochem. Sci. 16, 323–326 (1991).
Google Scholar
Niranjanakumari, S., Lasda, E., Brazas, R. & Garcia-Blanco, M. A. Reversible cross-linking combined with immunoprecipitation to study RNA–protein interactions in vivo. Methods 26, 182–190 (2002).
Google Scholar
Patton, R. D. et al. Chemical crosslinking enhances RNA immunoprecipitation for efficient identification of binding sites of proteins that photo-crosslink poorly with RNA. RNA 26, 1216–1233 (2020).
Google Scholar
Weissinger, R., Heinold, L., Akram, S., Jansen, R.-P. & Hermesh, O. RNA proximity labeling: a new detection tool for RNA–protein interactions. Molecules 26, 2270 (2021).
Google Scholar
Glisovic, T., Bachorik, J. L., Yong, J. & Dreyfuss, G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 582, 1977–1986 (2008).
Google Scholar
Jankowsky, E. & Harris, M. E. Specificity and nonspecificity in RNA-protein interactions. Nat. Rev. Mol. Cell Biol. 16, 533–544 (2015).
Google Scholar
Huppertz, I. et al. Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation. Mol. Cell 82, 2666–2680.e11 (2022).
Google Scholar
Hentze, M. W. et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238, 1570–1573 (1987).
Google Scholar
Castelló, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393–1406 (2012).
Google Scholar
Beckmann, B. M. et al. The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs. Nat. Commun. 6, 10127 (2015).
Google Scholar
Wassarman, K. M. & Storz, G. 6S RNA regulates E. coli RNA polymerase activity. Cell 101, 613–623 (2000).
Google Scholar
Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044–1066 (2020).
Google Scholar
Bou-Nader, C., Gordon, J. M., Henderson, F. E. & Zhang, J. The search for a PKR code-differential regulation of protein kinase R activity by diverse RNA and protein regulators. RNA 25, 539–556 (2019).
Google Scholar
Bjørkøy, G. et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603–614 (2005).
Google Scholar
Buscher, M. et al. Vault RNA1-1 riboregulates the autophagic function of p62 by binding to lysine 7 and arginine 21, both of which are critical for p62 oligomerization. RNA 28, 742–755 (2022).
Google Scholar
Liao, Y. et al. The cardiomyocyte RNA-binding proteome: links to intermediary metabolism and heart disease. Cell Rep. 16, 1456–1469 (2016).
Google Scholar
Riechert, E. et al. Identification of dynamic RNA-binding proteins uncovers a Cpeb4-controlled regulatory cascade during pathological cell growth of cardiomyocytes. Cell Rep. 35, 109100 (2021).
Google Scholar
Claycomb, W. C. et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl Acad. Sci. USA 95, 2979–2984 (1998).
Google Scholar
Frey, N. et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 10, 1336–1343 (2004).
Google Scholar
Frank, D. & Frey, N. Cardiac Z-disc signaling network. J. Biol. Chem. 286, 9897–9904 (2011).
Google Scholar
Xu, X. et al. ASF/SF2-regulated CaMKIIδ alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120, 59–72 (2005).
Google Scholar
Olson, E. N. Gene regulatory networks in the evolution and development of the heart. Science 313, 1922–1927 (2006).
Google Scholar
Srivastava, D. Genetic regulation of cardiogenesis and congenital heart disease. Annu. Rev. Pathol. 1, 199–213 (2006).
Google Scholar
Giudice, J. et al. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat. Commun. 5, 3603 (2014).
Google Scholar
Bohnsack, B. L., Lai, L., Northrop, J. L., Justice, M. J. & Hirschi, K. K. Visceral endoderm function is regulated by quaking and required for vascular development. Genesis 44, 93–104 (2006).
Google Scholar
Justice, M. J. & Hirschi, K. K. In: Post-Transcriptional Regulation by STAR Proteins: Control of RNA Metabolism in Development and Disease (eds. Volk, T. & Artzt, K.) 82–92 https://doi.org/10.1007/978-1-4419-7005-3_6 (Springer US, 2010).
Ding, J.-H. et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J. 23, 885–896 (2004).
Google Scholar
Feng, Y. et al. SRp38 regulates alternative splicing and is required for Ca2+ handling in the embryonic heart. Dev. Cell 16, 528–538 (2009).
Google Scholar
Gallagher, T. L. et al. Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. Dev. Biol. 359, 251–261 (2011).
Google Scholar
Frese, K. S. et al. RNA splicing regulated by RBFOX1 is essential for cardiac function in zebrafish. J. Cell Sci. 128, 3030–3040 (2015).
Google Scholar
Misra, C. et al. Aberrant expression of a non-muscle RBFOX2 isoform triggers cardiac conduction defects in myotonic dystrophy. Dev. Cell 52, 748–763.e6 (2020).
Google Scholar
Zhang, M. et al. Rbm24, a target of p53, is necessary for proper expression of p53 and heart development. Cell Death Differ. 25, 1118–1130 (2018).
Google Scholar
Yang, J. et al. RBM24 is a major regulator of muscle-specific alternative splicing. Dev. Cell 31, 87–99 (2014).
Google Scholar
Maatz, H. et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J. Clin. Invest. 124, 3419–3430 (2014).
Google Scholar
Guo, W. et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 18, 766–773 (2012).
Google Scholar
Raffel, G. D. et al. Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen. Mol. Cell Biol. 29, 333–341 (2009).
Google Scholar
Machuca-Tzili, L. E. et al. Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy. Dis. Model. Mech. 4, 381–392 (2011).
Google Scholar
Lee, K.-Y. et al. Mice lacking MBNL1 and MBNL2 exhibit sudden cardiac death and molecular signatures recapitulating myotonic dystrophy. Hum. Mol. Genet. 31, 3144–3160 (2022).
Google Scholar
Ladd, A. N., Taffet, G., Hartley, C., Kearney, D. L. & Cooper, T. A. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol. Cell Biol. 25, 6267–6278 (2005).
Google Scholar
Kalsotra, A. et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl Acad. Sci. USA 105, 20333–20338 (2008).
Google Scholar
Dewey, F. E. et al. Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circ. Cardiovasc. Genet. 4, 26–35 (2011).
Google Scholar
Dirkx, E., da Costa Martins, P. A. & De Windt, L. J. Regulation of fetal gene expression in heart failure. Biochim. Biophys. Acta 1832, 2414–2424 (2013).
Google Scholar
Park, J. Y. et al. Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS One 6, e22391 (2011).
Google Scholar
Gao, C. et al. RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure. J. Clin. Invest. 126, 195–206 (2016).
Google Scholar
Nakahata, S. & Kawamoto, S. Tissue-dependent isoforms of mammalian Fox-1 homologs are associated with tissue-specific splicing activities. Nucleic Acids Res. 33, 2078–2089 (2005).
Google Scholar
Chen, X. et al. QKI is a critical pre-mRNA alternative splicing regulator of cardiac myofibrillogenesis and contractile function. Nat. Commun. 12, 89 (2021).
Google Scholar
Montañés-Agudo, P. et al. The RNA-binding protein QKI governs a muscle-specific alternative splicing program that shapes the contractile function of cardiomyocytes. Cardiovasc. Res. 119, 1161–1174 (2023).
Google Scholar
Fagg, W. S. et al. Definition of germ layer cell lineage alternative splicing programs reveals a critical role for Quaking in specifying cardiac cell fate. Nucleic Acids Res. 50, 5313–5334 (2022).
Google Scholar
Gupta, S. K. et al. Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression. Circ. Res. 122, 246–254 (2018).
Google Scholar
Guo, W. et al. RNA binding protein QKI inhibits the ischemia/reperfusion-induced apoptosis in neonatal cardiomyocytes. Cell Physiol. Biochem. 28, 593–602 (2011).
Google Scholar
Verma, S. K. et al. RBFOX2 is required for establishing RNA regulatory networks essential for heart development. Nucleic Acids Res. 50, 2270–2286 (2022).
Google Scholar
Wei, C. et al. Repression of the central splicing regulator Rbfox2 is functionally linked to pressure overload-induced heart failure. Cell Rep. 10, 1521–1533 (2015).
Google Scholar
Huang, M. et al. Intrinsic myocardial defects underlie an Rbfox-deficient zebrafish model of hypoplastic left heart syndrome. Nat. Commun. 13, 5877 (2022).
Google Scholar
Verma, S. K. et al. Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts. Sci. Rep. 6, 30896 (2016).
Google Scholar
Xu, X. Q., Soo, S. Y., Sun, W. & Zweigerdt, R. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells 27, 2163–2174 (2009).
Google Scholar
Haas, J. et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur. Heart J. 36, 1123–1135 (2015).
Google Scholar
Wells, Q. S. et al. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Circ. Cardiovasc. Genet. 6, 317–326 (2013).
Google Scholar
van den Hoogenhof, M. M. G. et al. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling. Circulation 138, 1330–1342 (2018).
Google Scholar
Fenix, A. M. et al. Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies. Nat. Commun. 12, 6324 (2021).
Google Scholar
Schneider, J. W. et al. Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs. Nat. Med. 26, 1788–1800 (2020).
Google Scholar
Zhang, Y. et al. RBM20 phosphorylation and its role in nucleocytoplasmic transport and cardiac pathogenesis. FASEB J. 36, e22302 (2022).
Google Scholar
Ladd, A. N., Charlet-B, N. & Cooper, T. A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21, 1285–1296 (2001).
Google Scholar
Masuda, A. et al. CUGBP1 and MBNL1 preferentially bind to 3’ UTRs and facilitate mRNA decay. Sci. Rep. 2, 209 (2012).
Google Scholar
Kress, C., Gautier-Courteille, C., Osborne, H. B., Babinet, C. & Paillard, L. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol. Cell Biol. 27, 1146–1157 (2007).
Google Scholar
Giudice, J., Xia, Z., Li, W. & Cooper, T. A. Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1. Sci. Rep. 6, 35550 (2016).
Google Scholar
Kuyumcu-Martinez, N. M., Wang, G.-S. & Cooper, T. A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 28, 68–78 (2007).
Google Scholar
Morriss, G. R., Rajapakshe, K., Huang, S., Coarfa, C. & Cooper, T. A. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1. Hum. Mol. Genet. 27, 2789–2804 (2018).
Google Scholar
Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 19, 4439–4448 (2000).
Google Scholar
Artero, R. et al. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev. Biol. 195, 131–143 (1998).
Google Scholar
Lee, K.-Y. et al. Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med. 5, 1887–1900 (2013).
Google Scholar
Chang, C.-H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013).
Google Scholar
Matia-González, A. M., Laing, E. E. & Gerber, A. P. Conserved mRNA-binding proteomes in eukaryotic organisms. Nat. Struct. Mol. Biol. 22, 1027–1033 (2015).
Google Scholar
Libby, P. The changing landscape of atherosclerosis. Nature 592, 524–533 (2021).
Google Scholar
Bibli, S.-I. et al. Cystathionine γ lyase sulfhydrates the RNA binding protein human antigen R to preserve endothelial cell function and delay atherogenesis. Circulation 139, 101–114 (2019).
Google Scholar
Ford, L. P., Watson, J., Keene, J. D. & Wilusz, J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 13, 188–201 (1999).
Google Scholar
Dean, J. L. E. et al. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21, 721–730 (2001).
Google Scholar
Fu, X., Zhai, S. & Yuan, J. Endothelial HuR deletion reduces the expression of proatherogenic molecules and attenuates atherosclerosis. Int. Immunopharmacol. 65, 248–255 (2018).
Google Scholar
Yang, C. et al. Targeting QKI-7 in vivo restores endothelial cell function in diabetes. Nat. Commun. 11, 3812 (2020).
Google Scholar
Wardman, R. et al. RNA-binding proteins regulate post-transcriptional responses to TGF-β to coordinate function and mesenchymal activation of murine endothelial cells. Arterioscler. Thromb. Vasc. Biol. 43, 1967–1989 (2023).
Google Scholar
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R. & Mallat, Z. Vascular smooth muscle cells in atherosclerosis. Nat. Rev. Cardiol. 16, 727–744 (2019).
Google Scholar
Sachse, M. et al. RNA-binding proteins in vascular inflammation and atherosclerosis. Atherosclerosis 374, 55–73 (2023).
Google Scholar
Liu, S. et al. Smooth muscle-specific HuR knockout induces defective autophagy and atherosclerosis. Cell Death Dis. 12, 385 (2021).
Google Scholar
van der Veer, E. P. et al. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype. Circ. Res. 113, 1065–1075 (2013).
Google Scholar
Wolf, D. & Ley, K. Immunity and inflammation in atherosclerosis. Circ. Res. 124, 315–327 (2019).
Google Scholar
Yoshinaga, M. & Takeuchi, O. Post-transcriptional control of immune responses and its potential application. Clin. Transl. Immunol. 8, e1063 (2019).
Google Scholar
Kang, J.-G. et al. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. J. Immunol. 187, 2696–2701 (2011).
Google Scholar
Zhang, H. et al. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 33, 1212–1220 (2013).
Google Scholar
Le Tonqueze, O. et al. Regulation of monocyte induced cell migration by the RNA binding protein, FXR1. Cell Cycle 15, 1874–1882 (2016).
Google Scholar
Govindappa, P. K. et al. Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart. FASEB J. 34, 2238–2251 (2020).
Google Scholar
Shi, D.-L. RNA-binding proteins as critical post-transcriptional regulators of cardiac regeneration. Int. J. Mol. Sci. 24, 12004 (2023).
Google Scholar
Mathiyalagan, P. et al. FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair. Circulation 139, 518–532 (2019).
Google Scholar
Berulava, T. et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur. J. Heart Fail. 22, 54–66 (2020).
Google Scholar
Rigaud, V. O. C. et al. RNA-binding protein LIN28a regulates new myocyte formation in the heart through long noncoding RNA-H19. Circulation 147, 324–337 (2023).
Google Scholar
Hosen, M. R. et al. Airn regulates Igf2bp2 translation in cardiomyocytes. Circ. Res. 122, 1347–1353 (2018).
Google Scholar
Davis, J. et al. MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response. Nat. Commun. 6, 10084 (2015).
Google Scholar
Bugg, D. et al. MBNL1 drives dynamic transitions between fibroblasts and myofibroblasts in cardiac wound healing. Cell Stem Cell 29, 419–433.e10 (2022).
Google Scholar
Mudd, J. O. & Kass, D. A. Tackling heart failure in the twenty-first century. Nature 451, 919–928 (2008).
Google Scholar
Schultheiss, H.-P. et al. Dilated cardiomyopathy. Nat. Rev. Dis. Prim. 5, 32 (2019).
Google Scholar
Virani, S. S. et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 143, e254–e743 (2019).
Li, D. et al. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin. Transl. Sci. 3, 90–97 (2010).
Google Scholar
Brauch, K. M. et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 54, 930–941 (2009).
Google Scholar
Refaat, M. M. et al. Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm. 9, 390–396 (2012).
Google Scholar
Nishiyama, T. et al. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci. Transl. Med. 14, eade1633 (2022).
Google Scholar
Kong, S. W. et al. Heart failure-associated changes in RNA splicing of sarcomere genes. Circ. Cardiovasc. Genet. 3, 138–146 (2010).
Google Scholar
D’Antonio, M. et al. In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms. PLoS Comput. Biol. 18, e1009918 (2022).
Google Scholar
Boeckel, J.-N. et al. SLM2 Is a novel cardiac splicing factor involved in heart failure due to dilated cardiomyopathy. Genomics Proteom. Bioinforma. 20, 129–146 (2022).
Google Scholar
Asakura, M. & Kitakaze, M. Global gene expression profiling in the failing myocardium. Circ. J. 73, 1568–1576 (2009).
Google Scholar
Ramirez Flores, R. O. et al. Consensus transcriptional landscape of human end-stage heart failure. J. Am. Heart Assoc. 10, e019667 (2021).
Google Scholar
Gruber, A. J. & Zavolan, M. Alternative cleavage and polyadenylation in health and disease. Nat. Rev. Genet. 20, 599–614 (2019).
Google Scholar
Nourse, J., Spada, S. & Danckwardt, S. Emerging roles of RNA 3’-end cleavage and polyadenylation in pathogenesis, diagnosis and therapy of human disorders. Biomolecules 10, 915 (2020).
Google Scholar
Soetanto, R. et al. Role of miRNAs and alternative mRNA 3′-end cleavage and polyadenylation of their mRNA targets in cardiomyocyte hypertrophy. Biochim. Biophys. Acta 1859, 744–756 (2016).
Google Scholar
Creemers, E. E. et al. Genome-wide polyadenylation maps reveal dynamic mRNA 3’-end formation in the failing human heart. Circ. Res. 118, 433–438 (2016).
Google Scholar
Cao, J. & Kuyumcu-Martinez, M. N. Alternative polyadenylation regulation in cardiac development and cardiovascular disease. Cardiovasc. Res. 119, 1324–1335 (2023).
Google Scholar
Cao, J. et al. RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts. Cell Rep. 37, 109910 (2021).
Google Scholar
Mohan, N., Kumar, V., Kandala, D. T., Kartha, C. C. & Laishram, R. S. A splicing-independent function of RBM10 controls specific 3’ UTR processing to regulate cardiac hypertrophy. Cell Rep. 24, 3539–3553 (2018).
Google Scholar
Chorghade, S. et al. Poly(A) tail length regulates PABPC1 expression to tune translation in the heart. eLife 6, e24139 (2017).
Google Scholar
Geuens, T., Bouhy, D. & Timmerman, V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 135, 851–867 (2016).
Google Scholar
Gladka, M. M. et al. Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation. Circulation 138, 166–180 (2018).
Google Scholar
Martino, F. et al. The mechanical regulation of RNA binding protein hnRNPC in the failing heart. Sci. Transl. Med. 14, eabo5715 (2022).
Google Scholar
Thiele, B.-J. et al. RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis. Circ. Res. 95, 1058–1066 (2004).
Google Scholar
Chang, K.-T., Cheng, C.-F., King, P.-C., Liu, S.-Y. & Wang, G.-S. CELF1 mediates connexin 43 mRNA degradation in dilated cardiomyopathy. Circ. Res. 121, 1140–1152 (2017).
Google Scholar
Krishnamurthy, P. et al. Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J. 24, 2484–2494 (2010).
Google Scholar
Green, L. C. et al. Human antigen R as a therapeutic target in pathological cardiac hypertrophy. JCI Insight 4, 121541 (2019).
Google Scholar
Hu, X., Wu, P., Liu, B., Lang, Y. & Li, T. RNA-binding protein CELF1 promotes cardiac hypertrophy via interaction with PEBP1 in cardiomyocytes. Cell Tissue Res. 387, 111–121 (2022).
Google Scholar
Zaccara, S., Ries, R. J. & Jaffrey, S. R. Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 20, 608–624 (2019).
Google Scholar
Dorn, L. E. et al. The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation 139, 533–545 (2019).
Google Scholar
Kmietczyk, V. et al. m6A-mRNA methylation regulates cardiac gene expression and cellular growth. Life Sci. Alliance 2, e201800233 (2019).
Google Scholar
Doroudgar, S. et al. Monitoring cell-type-specific gene expression using ribosome profiling in vivo during cardiac hemodynamic stress. Circ. Res. 125, 431–448 (2019).
Google Scholar
van Heesch, S. et al. The translational landscape of the human heart. Cell 178, 242–260.e29 (2019).
Google Scholar
Schafer, S. et al. Translational regulation shapes the molecular landscape of complex disease phenotypes. Nat. Commun. 6, 7200 (2015).
Google Scholar
Petrosino, J. M. et al. The m6A methyltransferase METTL3 regulates muscle maintenance and growth in mice. Nat. Commun. 13, 168 (2022).
Google Scholar
Qin, Y. et al. Role of m6A RNA methylation in cardiovascular disease (Review). Int. J. Mol. Med. 46, 1958–1972 (2020).
Google Scholar
Schöller, E. et al. Interactions, localization, and phosphorylation of the m6A generating METTL3–METTL14–WTAP complex. RNA 24, 499–512 (2018).
Google Scholar
Wei, J. et al. Differential m6A, m6Am, and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol. Cell 71, 973–985.e5 (2018).
Google Scholar
Batista, P. J. et al. m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707–719 (2014).
Google Scholar
Li, M. et al. Ythdf2-mediated m6A mRNA clearance modulates neural development in mice. Genome Biol. 19, 69 (2018).
Google Scholar
Meyer, K. D. et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149, 1635–1646 (2012).
Google Scholar
Carnevali, L. et al. Signs of cardiac autonomic imbalance and proarrhythmic remodeling in fto deficient mice. PLoS One 9, e95499 (2014).
Google Scholar
Edupuganti, R. R. et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870–878 (2017).
Google Scholar
Perez-Perri, J. I. et al. Discovery of RNA-binding proteins and characterization of their dynamic responses by enhanced RNA interactome capture. Nat. Commun. 9, 4408 (2018).
Google Scholar
Arguello, A. E., DeLiberto, A. N. & Kleiner, R. E. RNA chemical proteomics reveals the N6-methyladenosine (m6A)-regulated protein–RNA interactome. J. Am. Chem. Soc. 139, 17249–17252 (2017).
Google Scholar
Wang, X. et al. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388–1399 (2015).
Google Scholar
Xu, H. et al. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy. Cell Biosci. 11, 132 (2021).
Google Scholar
Gao, S. et al. Depletion of m6 A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin. J. Cell Mol. Med. 25, 10879–10891 (2021).
Google Scholar
Han, Z. et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics 11, 3000–3016 (2021).
Google Scholar
Kmietczyk, V. et al. Ythdf2 regulates cardiac remodeling through its mRNA target transcripts. J. Mol. Cell Cardiol. 181, 57–66 (2023).
Google Scholar
Garlick, P. J., McNurlan, M. A. & Preedy, V. R. A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine. Biochem. J. 192, 719–723 (1980).
Google Scholar
Gudbjarnason, S., Telerman, M., Chiba, C., Wolf, P. L. & Bing, R. J. Myocardial protein synthesis in cardiac hypertrophy. J. Lab. Clin. Med. 63, 244–253 (1964).
Google Scholar
Zühlke, V., Du Mesnil de, R., Gudbjarnason, S. & Bing, R. J. Inhibition of protein synthesis in cardiac hypertrophy and its relation to myocardial failure. Circ. Res. 18, 558–572 (1966).
Google Scholar
Zimmer, H. G., Steinkopff, G. & Gerlach, E. Changes of protein synthesis in the hypertrophying rat heart. Pflügers Arch. Eur. J. Physiol. 336, 311–325 (1972).
Google Scholar
Zhang, G. et al. Integrated stress response couples mitochondrial protein translation with oxidative stress control. Circulation 144, 1500–1515 (2021).
Google Scholar
Volkers, M. et al. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1. Proc. Natl Acad. Sci. USA 110, 12661–12666 (2013).
Google Scholar
Varma, E. et al. Translational control of Ybx1 expression regulates cardiac function in response to pressure overload in vivo. Basic Res. Cardiol. 118, 25 (2023).
Google Scholar
Chothani, S. et al. Widespread translational control of fibrosis in the human heart by RNA-binding proteins. Circulation 140, 937–951 (2019).
Google Scholar
Walter, W. et al. Deciphering the dynamic transcriptional and post-transcriptional networks of macrophages in the healthy heart and after myocardial injury. Cell Rep. 23, 622–636 (2018).
Google Scholar
Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400–409 (2016).
Google Scholar
Litviňuková, M. et al. Cells of the adult human heart. Nature 588, 466–472 (2020).
Google Scholar
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Google Scholar
Schwarzl, T. Relative expression of human RNA-binding proteins (RBPs) in the human heart cell atlas. https://doi.org/10.5281/zenodo.8112712 (2023).
Frangogiannis, N. G. Cardiac fibrosis. Cardiovasc. Res. 117, 1450–1488 (2021).
Google Scholar
Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430–433 (2019).
Google Scholar
Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91–96 (2022).
Google Scholar
Stempien-Otero, A., Kim, D.-H. & Davis, J. Molecular networks underlying myofibroblast fate and fibrosis. J. Mol. Cell Cardiol. 97, 153–161 (2016).
Google Scholar
Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978–1980 (2003).
Google Scholar
Wang, E. T. et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 150, 710–724 (2012).
Google Scholar
Conn, S. J. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160, 1125–1134 (2015).
Google Scholar
Tombor, L. S. et al. Single cell sequencing reveals endothelial plasticity with transient mesenchymal activation after myocardial infarction. Nat. Commun. 12, 681 (2021).
Google Scholar
Shiojima, I. et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115, 2108–2118 (2005).
Google Scholar
Jabs, M. et al. Inhibition of endothelial notch signaling impairs fatty acid transport and leads to metabolic and vascular remodeling of the adult heart. Circulation 137, 2592–2608 (2018).
Google Scholar
de Bruin, R. G. et al. The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression. Sci. Rep. 6, 21643 (2016).
Google Scholar
Smith, M. R. & Costa, G. RNA-binding proteins and translation control in angiogenesis. FEBS J. 289, 7788–7809 (2022).
Google Scholar
van Mil, A. et al. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc. Res. 93, 655–665 (2012).
Google Scholar
Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047 (2007).
Google Scholar
Swirski, F. K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612–616 (2009).
Google Scholar
Hilgendorf, I. et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circulation Res. 114, 1611–1622 (2014).
Google Scholar
Liepelt, A. et al. Identification of RNA-binding proteins in macrophages by interactome capture. Mol. Cell Proteom. 15, 2699–2714 (2016).
Google Scholar
Kratochvill, F. et al. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation. Mol. Syst. Biol. 7, 560 (2011).
Google Scholar
Chen, C.-Y. A., Xu, N. & Shyu, A.-B. Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol. Cell. Biol. 22, 7268–7278 (2002).
Google Scholar
Krishnamurthy, P. et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circulation Res. 104, e9–e18 (2009).
Google Scholar
Steffens, S., Nahrendorf, M. & Madonna, R. Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies. Eur. Heart J. 43, 1533–1541 (2022).
Google Scholar
Leuschner, F. et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29, 1005–1010 (2011).
Google Scholar
Mohibi, S., Chen, X. & Zhang, J. Cancer the ’RBP’ eutics–RNA-binding proteins as therapeutic targets for cancer. Pharmacol. Ther. 203, 107390 (2019).
Google Scholar
Childs-Disney, J. L. et al. Targeting RNA structures with small molecules. Nat. Rev. Drug Discov. 21, 736–762 (2022).
Google Scholar
Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723–1732 (2017).
Google Scholar
Perez-Perri, J. I. et al. The RNA-binding protein landscapes differ between mammalian organs and cultured cells. Nat. Commun. 14, 2074 (2023).
Google Scholar
Thum, T. & Condorelli, G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 116, 751–762 (2015).
Google Scholar
Sahoo, S., Kariya, T. & Ishikawa, K. Targeted delivery of therapeutic agents to the heart. Nat. Rev. Cardiol. 18, 389–399 (2021).
Google Scholar
Nostrand, E. L. V. et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat. Methods 13, 508–514 (2016).
Google Scholar
Matia-González, A. M., Iadevaia, V. & Gerber, A. P. A versatile tandem RNA isolation procedure to capture in vivo formed mRNA-protein complexes. Methods 118-119, 93–100 (2016).
Google Scholar
Lorenz, D. A. et al. Multiplexed transcriptome discovery of RNA-binding protein binding sites by antibody-barcode eCLIP. Nat. Methods 20, 65–69 (2022).
Google Scholar
Asencio, C., Chatterjee, A. & Hentze, M. W. Silica-based solid-phase extraction of cross-linked nucleic acid-bound proteins. Life Sci. Alliance 1, e201800088 (2018).
Google Scholar
Zhao, J. et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939–953 (2010).
Google Scholar
Lin, C. & Miles, W. O. Beyond CLIP: advances and opportunities to measure RBP–RNA and RNA–RNA interactions. Nucleic Acids Res. 47, 5490–5501 (2019).
Google Scholar
Lee, F. C. Y. & Ule, J. Advances in CLIP technologies for studies of protein-RNA interactions. Mol. Cell 69, 354–369 (2018).
Google Scholar
Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141 (2010).
Google Scholar
König, J. et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol. 17, 909–915 (2010).
Google Scholar
Nostrand, E. L. V. et al. A large-scale binding and functional map of human RNA-binding proteins. Nature 583, 711–719 (2020).
Google Scholar
McHugh, C. A. et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 521, 232–236 (2015).
Google Scholar
Spiniello, M. et al. HyPR-MS for multiplexed discovery of MALAT1, NEAT1, and NORAD lncRNA protein interactomes. J. Proteome Res. 17, 3022–3038 (2018).
Google Scholar
Bos, T. J., Nussbacher, J. K., Aigner, S. & Yeo, G. W. Tethered function assays as tools to elucidate the molecular roles of RNA-binding proteins. Adv. Exp. Med. Biol. 907, 61–88 (2016).
Google Scholar
Bardwell, V. J. & Wickens, M. Purification of RNA and RNA-protein complexes by an R17 coat protein affinity method. Nucleic Acids Res. 18, 6587–6594 (1990).
Google Scholar
De Gregorio, E., Preiss, T. & Hentze, M. W. Translation driven by an eIF4G core domain in vivo. EMBO J. 18, 4865–4874 (1999).
Google Scholar
Tsai, B. P., Wang, X., Huang, L. & Waterman, M. L. Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach. Mol. Cell Proteom. 10, M110.007385 (2011).
Google Scholar
Caudron-Herger, M., Jansen, R. E., Wassmer, E. & Diederichs, S. RBP2GO: a comprehensive pan-species database on RNA-binding proteins, their interactions and functions. Nucleic Acids Res. 49, D425–D436 (2021).
Google Scholar
Hiller, M. et al. The mRNA binding proteome of proliferating and differentiated muscle cells. Genomics Proteom. Bioinforma. 18, 384–396 (2020).
Google Scholar
Zhang, Z. et al. An RNA tagging approach for system-wide RNA-binding proteome profiling and dynamics investigation upon transcription inhibition. Nucleic Acids Res. 49, gkab156 (2021).
Google Scholar
Bao, X. et al. Capturing the interactome of newly transcribed RNA. Nat. Methods 15, 213–220 (2018).
Google Scholar
Huang, R., Han, M., Meng, L. & Chen, X. Transcriptome-wide discovery of coding and noncoding RNA-binding proteins. Proc. Natl Acad. Sci. USA 115, E3879–E3887 (2018).
Google Scholar
Trendel, J. et al. The human RNA-binding proteome and its dynamics during translational arrest. Cell 176, 391–403.e19 (2019).
Google Scholar
Queiroz, R. M. L. et al. Comprehensive identification of RNA–protein interactions in any organism using orthogonal organic phase separation (OOPS). Nat. Biotechnol. 37, 169–178 (2019).
Google Scholar
Urdaneta, E. C. et al. Purification of cross-linked RNA-protein complexes by phenol-toluol extraction. Nat. Commun. 10, 990 (2019).
Google Scholar
Castelló, A. et al. Comprehensive identification of RNA-binding domains in human cells. Mol. Cell 63, 696–710 (2016).
Google Scholar
Panhale, A. et al. CAPRI enables comparison of evolutionarily conserved RNA interacting regions. Nat. Commun. 10, 2682 (2019).
Google Scholar
Bae, J. W., Kim, S., Kim, V. N. & Kim, J.-S. Photoactivatable ribonucleosides mark base-specific RNA-binding sites. Nat. Commun. 12, 6026 (2021).
Google Scholar
Bae, J. W., Kwon, S. C., Na, Y., Kim, V. N. & Kim, J.-S. Chemical RNA digestion enables robust RNA-binding site mapping at single amino acid resolution. Nat. Struct. Mol. Biol. 27, 678–682 (2020).
Google Scholar
Gray, N. K., Pantopoulos, K., Dandekar, T., Ackrell, B. A. & Hentze, M. W. Translational regulation of mammalian and Drosophila citric acid cycle enzymes via iron-responsive elements. Proc. Natl Acad. Sci. USA 93, 4925–4930 (1996).
Google Scholar
Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24–38 (2010).
Google Scholar
Horos, R. et al. The small non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell 176, 1054–1067.e12 (2019).
Google Scholar
Hirose, T., Ninomiya, K., Nakagawa, S. & Yamazaki, T. A guide to membraneless organelles and their various roles in gene regulation. Nat. Rev. Mol. Cell Biol. 24, 288–304 (2023).
Google Scholar
Evguenieva-Hackenberg, E. Riboregulation in bacteria: from general principles to novel mechanisms of the trp attenuator and its sRNA and peptide products. Wiley Interdiscip. Rev. RNA 13, e1696 (2022).
Google Scholar
Guiducci, G. et al. The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism. Nucleic Acids Res. 47, 4240–4254 (2019).
Google Scholar
Monti, M. et al. Modelling of SHMT1 riboregulation predicts dynamic changes of serine and glycine levels across cellular compartments. Comput. Struct. Biotechnol. J. 19, 3034–3041 (2021).
Google Scholar
